UPS has entered into a definitive purchase agreement to acquire Marken, a global provider of supply chain solutions to the life sciences industry.
UPS has entered into a definitive purchase agreement to acquire Marken, a global provider of supply chain solutions to the life sciences industry.
The transaction, which provides UPS with growth opportunities across the life sciences customer base, is expected to close by 31 December, subject to customary conditions and regulatory approvals. Terms of the acquisition were not disclosed.
The acquisition of Marken follows multiple UPS acquisitions that have expanded the company’s healthcare logistics services portfolio.
“Healthcare logistics is a strategic market for UPS. Our acquisition of Marken strengthens our portfolio and demonstrates our commitment to customers,” said Teresa Finley, UPS chief marketing and business services officer. “We plan to offer new solutions to our customers and generate further growth opportunities for UPS.”
“We are excited to join the UPS organization,” said Wes Wheeler, Marken’s chief executive officer. “UPS’s capabilities, particularly in mature markets, will provide many opportunities for us to enhance our service offerings in clinical trials logistics.
"With UPS, we will improve our efficiency, while continuing to provide our clients with the high-touch, personalised services that they have come to expect from us.”